Previous Section
Drug Therapy
1. Pramipexole: in restless legs syndrome.
- Author
- McCormack PL; Siddiqui MA;
- Institution
- Wolters Kluwer Health | Adis, Auckland, New Zealand, an editorial office of Wolters Kluwer Health, Conshohocken, Pennsylvania, USA.
- Journal
- CNS Drugs. 2007;21(5):429-37.
- Abstract URL
- Click here to view abstract
2. Augmentation of restless legs syndrome with long-term tramadol treatment.
- Author
- Vetrugno R; La Morgia C; D'Angelo R; Loi D; Provini F; Plazzi G; Montagna P;
- Institution
- Department of Neurological Sciences, University of Bologna, Bologna, Italy. vetrugno@neuro.unibo.it
- Journal
- Mov Disord. 2007 Feb 15;22(3):424-7.
- Abstract URL
- Click here to view abstract
3. Pregabalin in restless legs syndrome with and without neuropathic pain.
- Author
- Sommer M; Bachmann CG; Liebetanz KM; Schindehutte J; Tings T; Paulus W;
- Institution
- Department of Clinical Neurophysiology, University of Goettingen, Goettingen, Germany. msommer@med.uni-goettingen.de
- Journal
- Acta Neurol Scand. 2007 May;115(5):347-50.
- Abstract URL
- Click here to view abstract
4. First night efficacy of pramipexole in restless legs syndrome and periodic leg movements.
- Author
- Manconi M; Ferri R; Zucconi M; Oldani A; Fantini ML; Castronovo V; Ferini-Strambi L;
- Institution
- Sleep Disorders Center, Department of Neurology, Scientific Institute and University Ospedale San Raffaele, Vita-Salute University, Milan, Italy.
- Journal
- Sleep Med. 2007 May 17;.
- Abstract URL
- Click here to view abstract
5. Methadone for refractory restless legs syndrome.
- Author
- Ondo, William G;
- Institution
- Baylor College of Medicine, Houston Texas 77030-2744, USA. wondo@bcm.tmc.edu
- Journal
- Mov Disord. 2005 Mar;20(3):345-8.
- Abstract URL
- Click here to view abstract
6. Repeated IV doses of iron provides effective supplemental treatment of restless legs syndrome.
- Author
- Earley CJ; Heckler D; Allen RP;
- Institution
- Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD, USA. cearley@jhmi.edu
- Journal
- Sleep Med. 2005 Jul;6(4):301-5. Epub 2005 Apr 1.
- Abstract URL
- Click here to view abstract
7. Restless legs syndrome: Diagnostic assessment and the advantages and risks of dopaminergic treatment.
- Author
- Hogl B; Paulus W; Clarenbach P; Trenkwalder C;
- Institution
- Dept. of Neurology, Medical University, 6020, Innsbruck, Austria, birgit.ho@uibk.ac.at.
- Journal
- J Neurol. 2006 Aug;253 Suppl 4:iv22-iv28.
- Abstract URL
- Click here to view abstract
8. Efficacy and tolerability of ropinirole in patients with restless legs syndrome and a baseline IRLS total score > or = 24 points--data from the ropinirole clinical trial programme.
- Author
- Giorgi L; Ritchie SY; Kirsch JM;
- Institution
- GlaxoSmithKline, Greenford, UK. luigi.2.giorgi@gsk.com
- Journal
- Curr Med Res Opin. 2006 Oct;22(10):1867-77.
- Abstract URL
- Click here to view abstract
9. Medication tolerance and augmentation in restless legs syndrome: the need for drug class rotation.
- Author
- Kurlan R; Richard IH; Deeley C; Kurlan R; Richard IH; Deeley C;
- Institution
- Movement Disorders Unit, Department of Neurology, University of Rochester School of Medicine, Rochester, NY, USA.
- Journal
- J Gen Intern Med. 2006 Dec;21(12):C1-4.
- Abstract URL
- Click here to view abstract
10. Long-term treatment with pramipexole in restless legs syndrome.
- Author
- Montplaisir J; Fantini ML; Desautels A; Michaud M; Petit D; Filipini D;
- Institution
- Centre d'etude du sommeil et des rythmes biologiques, Hopital du Sacre-Coeur de Montreal, Universite de Montreal, QC, Canada. jy.montplaisir@umontreal.ca
- Journal
- Eur J Neurol. 2006 Dec;13(12):1306-11.
- Abstract URL
- Click here to view abstract
Next: Clinical Trials
